10th Computational Drug Development For Biologics Summit 2025

The landscape of biologics discovery is rapidly evolving, driven by breakthroughs in AI, an influx of high-quality datasets, and regulatory momentum supporting in silico approaches. As industry leaders look to streamline R and D and de-risk development, there is a critical need for cutting-edge tools in modeling, characterization, screening, and developability.

Speakers: Abhinav Gupta, Senior Scientist - Artificial Intelligence Innovation for Antibody, Sanofi, Andrew Wollacott, Sr. Director, Research, Visterra, Gabor Oroszlan, In Silico Lead, Project Manager, Senior Scientist, VRG Therapeutics, Gopal Karemore, Global Quantum Lead in Healthcare and Life Sciences, IBM, James Bowman, Senior Investigator and Director - Protein Engineeering, AI Proteins, Jenna Caldwell, Associate Principal Scientist, AstraZeneca, Jinbo Xu, Professor, Toyota Technological Institute at Chicago, Jing Wang, Director, Eli Lilly and Co., Joel Karpiak, Senior Director, Head of Protein Design and Informatics, GlaxoSmithKline, Kannan Sankar, Senior Expert - Data Science and Bioinformatics, Novartis, Mark Aquino, Principal Data Scientist II, AbbVie, Natnael Hamda, Associate Director AI ML Research Scientist (Early Drug Discovery), Astellas Pharma, Neeraj Agrawal, Director, Attribute Sciences, Process Development, Amgen, Norbert Furtmann, Head of AI Innovation - Large Molecules Research, Sanofi, Radoslav Enchev, Group Leader, The Francis Crick Institute, Ryan Emerson, SVP, Data Science and GM, Platform Solutions, A-Alpha Bio Inc., Shipra Malhotra, Senior Scientist - Biologics, Computational and Machine Learning, Takeda Pharmaceutical, Talip Uçar, Senior Director, AI Research, AstraZeneca, Yao Fan, Director - Protein Design and Optimization, Tectonic Therapeutic